Compare CDIO & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDIO | VSTD |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | 17 | 259 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.4M |
| IPO Year | N/A | N/A |
| Metric | CDIO | VSTD |
|---|---|---|
| Price | $1.97 | $0.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 57.1K | ★ 74.6K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $171,906.75 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.97 | $0.20 |
| 52 Week High | $7.91 | $2.20 |
| Indicator | CDIO | VSTD |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 33.71 |
| Support Level | $1.72 | $0.22 |
| Resistance Level | $2.13 | $0.37 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 13.57 | 11.72 |
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Vestand Inc is a California-based fast-growing restaurant operator expanding into the real estate investment and development sector. It is a PropTech company engaged in AI-driven real estate investment and security token offerings (STOs). It provides services such as Property Acquisition, Property Development, Financial Management, and Property Management.